Immunax is an immune-modulating Macrophage Activating Protein (iMAP) designed to support immune-compromised patients.
Immunax is an immune-modulating Macrophage Activating Protein (iMAP). A stabilized vitamin D protein complex designed to regulate and enhance immune function. The biochemical term for the naturally-occurring messenger protein is Vitamin D Binding Protein Macrophage Activating Factor (VDBP-MAF).
Research shows that iMAP therapy has therapeutic potential for immune-related disorders and patients with compromised immune systems. Immunax can also be beneficial for routine immune enhancement in healthy individuals, especially as we age.
Lyophilized product
No cold-chain shipping or storage
Stable shelf-life at room temperature for over 1 year
Classified as a nutritional supplement
Made in GMP certified lab
Third-party tested for sterility
Confirmed transcriptomic verification of activity
Exceeds LPS standard activation of macrophages
VDBP-MAF is a functional protein that regulates the immune response.
Think of it as the commanding officer of the immune system, helping to
coordinate immune cell activity.
Healthy individuals produce sufficient levels of VDBP-MAF, enabling them to mount an effective immune response against cancer cells, harmful bacteria, viruses and other pathogens.
Unfortunately, VDBP-MAF is often suppressed in patients with chronic diseases. iMAP therapy may provide therapeutic benefits for a range of conditions, including:
Cancer
Neurological disorders
Autoimmune conditions
Chronic infections
Immune enhancement
VDBP-MAF has been studied in the context of various chronic health conditions related to immune dysfunction. Research indicates that Immunax may help to:
Combat cancer
Restore and balance the immune system
Reduce cancer treatment-related side effects
Improve brain function and prevent cognitive decline
Protect and repair the nervous system
Increase cellular energy levels
Enhance overall health and well-being
Over 160 peer-reviewed papers have been published over the past 30+ years on VDBP-MAF. The scientific literature reports several key mechanisms of this immune-modulating protein. For references, visit the research page of the Immunax website.
Activates macrophages, which kill cancer cells.
Inhibits angiogenesis reducing blood supply to tumors.
Inhibits proliferation and metastasis of cancer cells.
Transforms cancer cells into healthy cells (reverts phenotype).
Induces apoptosis in cancer cells.
Suppresses HER2 oncogene expression.
Repairs human neurons and promotes neurogenesis.
Increases mitochondrial energy production.
Normalizes endocannabinoid gene expression.
Induces nitric oxide synthesis and release.
Counteracts chemotherapy-induced neuropathy.
Activates osteoclasts and promotes bone resorption.
At ReGenMed we pride ourselves on our ability to support medical professionals and enhance patient outcomes. Get in touch with a member of our team today to find out more.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results may vary, and individual outcomes are not guaranteed.
Your trusted biomedicine provider since 2007.
Copyright @ Regenerative Medicine Co, Ltd. All Rights Reserved
